Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page history now shows a new revision tag, v3.5.4, added to the study record history. This updates the record with a newer revision, replacing the prior v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T03:06:27.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    A minor platform/version indicator on the page changes from Revision: v3.5.2 to Revision: v3.5.3, with no visible update to the underlying trial record history.
    Difference
    0.1%
    Check dated 2026-04-23T21:54:11.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The study record history shows the addition of Revision: v3.5.2 and the deletion of Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T12:39:06.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision History updated to include Revision: v3.5.0 and remove Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:40:01.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:55:05.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    A new revision entry (Revision: v3.4.2) was added to the record history, and the notice about government funding lapse as well as the previous revision (v3.4.1) were removed.
    Difference
    0.9%
    Check dated 2026-02-11T09:18:42.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.